OriGene Technologies
Latest round
- Series D
Last raised
- Jun 2015
Total raised
- $54M
Investors
- 9
About OriGene Technologies
OriGene Technologies, Inc.Founded in 1995 and headquartered in Rockville, US, OriGene Technologies, Inc. specializes in developing and supplying genomic tools. The company has undergone various strategic adjustments to enhance its product offerings, but specific shifts are not documented.OriGene Technologies Inc. specializes in a diverse range of products and services primarily focused on genomics and proteomics. The company’s core offerings include validated antibodies, cDNA clones, lentiviral products, RNA interference (RNAi) tools, and a variety of recombinant proteins. These products are designed for use in research settings, particularly in the fields of molecular biology, cell biology, and cancer research. OriGene’s products facilitate advanced research applications such as gene expression analysis, protein purification, and functional studies in various biological contexts, serving a global clientele that includes academic research institutions, biotech firms, and pharmaceutical companies.OriGene Technologies Inc. generates revenue through direct sales of its extensive product portfolio, which includes flagship offerings such as the GFAP Rabbit Polyclonal Antibody and various cDNA clones. Transactions typically occur through a business-to-business (B2B) model, with customers placing orders via the company's website or through direct partnerships. Products are available for purchase individually or as part of bundled solutions for enhanced value. Pricing structures are aligned with the specific needs of researchers and institutions.OriGene Technologies, Inc. plans to expand its product line with new innovations in genomic tools, aiming for launches in the coming years. The most recent deal on June 1, 2016, involved Merieux Equity Partners exiting its stake in the company.
Who invested in OriGene Technologies
9 investors across 3 rounds
See all investors in OriGene Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OriGene Technologies
Who invested in OriGene Technologies?
OriGene Technologies has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OriGene Technologies raised?
OriGene Technologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did OriGene Technologies last raise money?
OriGene Technologies's most recent round on record is a Series D, in Jun 2015.
What does OriGene Technologies do?
OriGene Technologies is a biotechnology company.
Where is OriGene Technologies headquartered?
OriGene Technologies is headquartered in Rockville, US.
Which VCs invest in companies like OriGene Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at OriGene Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like OriGene Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.